Xenon Pharmaceuticals Inc (NASDAQ:XENE)
| 28.50 BATS BZX Real-Time Price As of 3:28pm ET |  -0.74 / -2.53%Today’s Change | 14.65 Today|||52-Week Range 36.42 | -8.77% Year-to-Date |
Latest XENE News | Press Releases
| Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Misses Revenue Estimates May 10 / Zacks.com - Paid Partner Content | Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Lags Revenue Estimates May 09 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 29.24 |
| Today’s open | 29.15 |
| Day’s range | 28.44 - 29.64 |
| Volume | 15,971 |
| Average volume (3 months) | 460,075 |
| Market cap | $1.6B |
Data as of 3:28pm ET, 05/19/2022
Growth & Valuation
| Earnings growth (last year) | -117.87% |
| Earnings growth (this year) | -15.07% |
| Earnings growth (next 5 years) | +61.10% |
| Revenue growth (last year) | -42.68% |
| P/E ratio | NM |
| Price/Sales | 73.92 |
| Price/Book | 2.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HCMHUTCHMED (China) Ltd | +0.26 | +2.91% |
| ---- | ||
| ---- | ||
| ---- |
Data as of 3:24pm ET, 05/19/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $18.4M |
| Annual profit (last year) | -$78.9M |
| Net profit margin | -427.85% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Burnaby, British Columbia |
Forecasts
